These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 4727375

  • 1. [Effects of spironolactone on myocardial hyperexcitability in decompensated heart failure].
    Tourniaire A, Blum J.
    Coeur Med Interne; 1973; 12(1):147-52. PubMed ID: 4727375
    [No Abstract] [Full Text] [Related]

  • 2. [Effect of spironolactone on the myocardial hyperexcitability of decompensated cardiopathies].
    Tourniaire A, Blum J, Guyot R, Madignier M.
    Lyon Med; 1965 Dec 05; 214(49):1219-31. PubMed ID: 5859396
    [No Abstract] [Full Text] [Related]

  • 3. [Myocardial hyperexcitability in decompensated cardiopathies. Effect of spironolactone].
    Tourniaire A, Blum J, Guyot R, Madignier M.
    Sem Hop; 1969 Apr 26; 45(20):1388-92. PubMed ID: 4182541
    [No Abstract] [Full Text] [Related]

  • 4. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E, Mangiavacchi M, Andreuzzi B, Municinò A.
    Ital Heart J Suppl; 2001 Dec 26; 2(12):1278-83. PubMed ID: 11838348
    [Abstract] [Full Text] [Related]

  • 5. [Aldosterone antagonists in coronary insufficiency].
    Osswald H.
    Med Klin; 1978 Jan 20; 73(3):84-8. PubMed ID: 622061
    [No Abstract] [Full Text] [Related]

  • 6. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure.
    Gao X, Peng L, Adhikari CM, Lin J, Zuo Z.
    J Card Fail; 2007 Apr 20; 13(3):170-7. PubMed ID: 17448413
    [Abstract] [Full Text] [Related]

  • 7. [Intolerance to spironolactone in refractory cardiac insufficiency. Probable changes in the aldosterone receptors. Study of 11 cases].
    Sänchez Torres G, Posadas C, Boyer JL, Guzmán Lara J, Serrano P.
    Arch Inst Cardiol Mex; 1981 Apr 20; 51(3):233-40. PubMed ID: 6456707
    [No Abstract] [Full Text] [Related]

  • 8. [Long-term domiciliary oxygen therapy of cardiac failure and cardiac arrhythmia accompanying respiratory insufficiency (author's transl)].
    Daum S, Goerg R, Schlehe H, Wang D.
    Prax Klin Pneumol; 1981 Nov 20; 35(11):532-7. PubMed ID: 6808483
    [No Abstract] [Full Text] [Related]

  • 9. [Value of successive use of aldactone and aldactacine in the management of congestive heart failure involving at the outset hypokalemia with or without cardiac rhythm disorders].
    Koate P, Diouf S, Sylla M, Diop G, Diop SN.
    Dakar Med; 1981 Nov 20; 26(1):1-11. PubMed ID: 7238279
    [No Abstract] [Full Text] [Related]

  • 10. Spironolactone has antiarrhythmic activity in ischaemic cardiac patients without cardiac failure.
    Shah NC, Pringle SD, Donnan PT, Struthers AD.
    J Hypertens; 2007 Nov 20; 25(11):2345-51. PubMed ID: 17921831
    [Abstract] [Full Text] [Related]

  • 11. [Comparison of the therapeutic efficacy of spironolactone and furosemide in patients with severe congestive heart failure].
    Bednarz B, Cybulski J, Chamiec T.
    Pol Merkur Lekarski; 2000 Aug 20; 9(50):519-21. PubMed ID: 11081314
    [Abstract] [Full Text] [Related]

  • 12. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
    Bauersachs J, Fraccarollo D.
    Minerva Cardioangiol; 2003 Apr 20; 51(2):155-64. PubMed ID: 12783071
    [Abstract] [Full Text] [Related]

  • 13. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr 20; 15(82):46-9. PubMed ID: 16604728
    [Abstract] [Full Text] [Related]

  • 14. [Spironolactone in digitalis-requiring cardiac insufficiency following pacemaker implantation].
    Sabin G, Klüsener W.
    Med Klin; 1981 Jan 02; 76(1):20-3. PubMed ID: 7254119
    [Abstract] [Full Text] [Related]

  • 15. Spironolactone in patients with heart failure.
    Larkin RJ, Atlas SA, Donohue TJ.
    N Engl J Med; 2000 Jan 13; 342(2):132-3; author reply 133-4. PubMed ID: 10636751
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of heart failure: update 1994.
    Krueger SK, Mahapatra S, Gangahar DM, Wilson CS, Turk KT, Vermaas PL.
    Nebr Med J; 1994 Aug 13; 79(8):292-7. PubMed ID: 7990994
    [No Abstract] [Full Text] [Related]

  • 17. [The process of drug development. The "case" of spironolactone].
    De Feo S, Opasich C, Volpi A, Tavazzi L.
    Ital Heart J Suppl; 2002 Feb 13; 3(2):178-86. PubMed ID: 11926024
    [Abstract] [Full Text] [Related]

  • 18. [Heart failure and arrhythmia. Prognostic and therapeutic concepts].
    Manz M, Lüderitz B.
    Internist (Berl); 1993 Oct 13; 34(10):944-52. PubMed ID: 8225844
    [No Abstract] [Full Text] [Related]

  • 19. [Spironolactone: renaissance of anti-aldosterone therapy in heart failure?].
    Brilla CG, Schencking M, Scheer C, Rupp H.
    Praxis (Bern 1994); 1997 Apr 02; 86(14):566-74. PubMed ID: 9198851
    [Abstract] [Full Text] [Related]

  • 20. Transcardiac gradient of aldosterone before and after spironolactone in patients with congestive heart failure.
    Tsutamoto T, Wada A, Maeda K, Hayashi M, Tsutsui T, Ohnishi M, Fujii M, Matsumoto T, Yamamoto T, Takayama T, Ishii C.
    J Cardiovasc Pharmacol; 2003 Jan 02; 41 Suppl 1():S19-22. PubMed ID: 12688391
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.